Nicole Murphy
CIK 1910644 · Head of Pharm Ops and Tech · last filed 2026-02-17
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$3.92M
Companies
1
Total Filings
20
Lifetime Open-Market Net
$585
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| BIIB | Head of Pharm Ops and Tech | 19,611 | $200.05 | $3.92M | $585 | 20 | 2026-02-17 |
Recent Filings · Page 2 of 2
20 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-02-22 | BIIB | Mixed | +247 | -$64.9K | EDGAR |
| 2023-02-14 | BIIB | Mixed | +1,224 | -$397.1K | EDGAR |
| 2023-02-10 | BIIB | Grant (A) | — | $0 | EDGAR |
| 2023-01-27 | BIIB | Grant (A) | +1,340 | $0 | EDGAR |
| 2022-12-06 | BIIB | Mixed | +92 | -$11.7K | EDGAR |
| 2022-08-03 | BIIB | Mixed | +761 | -$66.8K | EDGAR |
| 2022-04-05 | BIIB | Mixed | +155 | -$17.7K | EDGAR |
| 2022-02-23 | BIIB | Mixed | +261 | -$23.1K | EDGAR |
| 2022-02-15 | BIIB | Mixed | +171 | -$19.7K | EDGAR |
| 2022-02-14 | BIIB | Grant (A) | — | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.